The AccessDx COVID-19 diagnostic test quickly identifies pathogens including SARSCoV-2 (COVID-19) so effective actions can begin sooner. AccessDx offers a high-quality clinical-grade RT-PCR test that has been made available pursuant to the FDA's Emergency Use Authorization (EUA) for diagnostic testing in CLIA-certified laboratories.
With a national service footprint, AccessDx is a CLIA (#45D2034771), CAP-accredited, and New York State certified diagnostic laboratory with extensive experience in genetic testing, PCR, toxicology, and pathogen detection.
We are ready to help serve the needs of your group. In addition to standard lab data integrations, we are providing a full telemedicine option that can evaluate symptomatic employees and facilitate rapid diagnostic testing as necessary.
We make sure that every client who is on boarded has their needs met by our services.
Member sees provider or completes online assessment
Provider reviews assessment( if qualified completes encounter)
(Centralized kit availability or direct ship)
In addition to a standalone COVID-19 panel, AccessDx offers a COVID-19+RPP panel that also quickly identifies the presence of over 28 additional pathogens to help aid in clinical decision-making.